Affinity of β-Lactam Antibiotics for Neisseria gonorrhoeae Penicillin-Binding Protein 2 Having Wild, Cefixime-Reduced-Susceptible, and Cephalosporin (Ceftriaxone)-Resistant penA Alleles
Microbial Drug Resistance · 2024
DOI: 10.1089/mdr.2023.0256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, 2024. Verfasst von Yoshiki Hiyama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Ceftriaxone, Gonorrhea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Multidrug-resistant Neisseria gonorrhoeae is a serious concern worldwide. Resistance to β-lactam antibiotics occurs through mutations in penicillin-binding proteins (PBPs), acquisition of β-lactamases, and alteration of antibiotic penetration. Mosaic structures of penA , which encodes PBP2, play a major role in resistance to β-lactams, especially cephalosporins. Ceftriaxone (CRO) is recognized as the only satisfiable antibiotic for the treatment of gonococcal infections; however, CRO-resistant isolates have emerged in the community. Here, we examined the affinity of β-lactam antibiotics for recombinant PBP2 in a competition assay using fluorescence-labeled penicillin. We found no or little difference in the affinities of penicillins and meropenem (MEM) for PBP2 from cefixime (CFM)-reduced-susceptible strain and cephalosporin-resistant strain. However, the affinity of cephalosporins, including CRO, for PBP2 from the cephalosporin-resistant strain was markedly lower than that for PBP2 from the CFM-reduced-susceptible-resistant strain. Notably, piperacillin (PIP) showed almost the same affinity for PBP2 from penicillin-susceptible, CFM-reduced-susceptible, and cephalosporin (including CRO)-resistant strains. Thus, PIP/tazobactam and MEM are candidate antibiotics for the treatment of CRO-resistant/multidrug-resistant N. gonorrhoeae .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Urology, NTT Medical Center Sapporo, Sapporo, Japan.
- Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Laboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
- Graduate School of Infectious Diseases, Hokkaido University, Sapporo, Japan.
- One Health Research Center, Hokkaido University, Sapporo, Japan.
Zitieren
APA
Hiyama, Y., Yamamoto, S., Sato, T., Ogasawara, N., Masumori, N., Takahashi, S., & Yokota, S. I. (2024). Affinity of β-Lactam Antibiotics for Neisseria gonorrhoeae Penicillin-Binding Protein 2 Having Wild, Cefixime-Reduced-Susceptible, and Cephalosporin (Ceftriaxone)-Resistant penA Alleles. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2023.0256
Vancouver
Hiyama Y, Yamamoto S, Sato T, Ogasawara N, Masumori N, Takahashi S, et al. Affinity of β-Lactam Antibiotics for Neisseria gonorrhoeae Penicillin-Binding Protein 2 Having Wild, Cefixime-Reduced-Susceptible, and Cephalosporin (Ceftriaxone)-Resistant penA Alleles. Microbial Drug Resistance. 2024. doi:10.1089/mdr.2023.0256
BibTeX
@article{Hiyama2024,
author = {Hiyama, Yoshiki and Yamamoto, Soh and Sato, Toyotaka and Ogasawara, Noriko and Masumori, Naoya and Takahashi, Satoshi and Yokota, Shin-Ichi},
title = {Affinity of β-Lactam Antibiotics for Neisseria gonorrhoeae Penicillin-Binding Protein 2 Having Wild, Cefixime-Reduced-Susceptible, and Cephalosporin (Ceftriaxone)-Resistant penA Alleles},
journal = {Microbial Drug Resistance},
year = {2024},
doi = {10.1089/mdr.2023.0256}
}
EUVIMED